Will My GP Prescribe Mounjaro for Weight Loss?

You've asked your GP about Mounjaro, here's what shapes the answer

Picture the consultation: you mention you've read about Mounjaro, your GP nods, and then there's a pause. That pause usually reflects two separate questions your doctor is working through simultaneously: first, is this patient clinically suitable? Second, is my practice actually set up to prescribe it on the NHS yet?

On the clinical side, your GP will consider your BMI, any weight-related conditions you have, your medical history and any medicines you already take. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. That's the private-prescription threshold. The NHS bar is considerably higher, and that's where the second question bites.

NHS prescribing follows NICE's appraisal of tirzepatide (TA1026), which sets phased eligibility. Right now, NHS patients need a BMI of at least 40 plus four or more of five specific conditions: type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease. Even if you tick those boxes, your GP's practice must have opted into the scheme, participation under the April 2026 QOF contract is voluntary, so some practices are prescribing and some aren't yet. You can read more about whether the NHS will prescribe Mounjaro and the full phase timeline.

Why your GP might say no, even if you're a good candidate

A GP saying no to Mounjaro doesn't necessarily mean they think you're not suitable. Several practical barriers exist that have nothing to do with your health.

Some practices haven't yet registered for the NHS tirzepatide pathway. Others are registered but have a backlog of patients already in the queue ahead of you. There are also GPs who are cautious about a medicine that carries a Black Triangle designation, meaning it's still under additional MHRA monitoring while longer-term real-world data accumulates. That caution is reasonable, not a rebuff.

It's also worth knowing that the eligibility thresholds will loosen over time. The next NHS phase, covering people with a BMI of 35 to 39.9 and four or more qualifying conditions, activated in June 2026. A further expansion to BMI ≥40 with three conditions is expected around March 2027. So a no today may become a yes within months, worth asking your GP when they'd revisit it. Whether a GP can prescribe Mounjaro and whether yours will right now are genuinely different questions.

If you want to understand what a private assessment looks like as a comparison, the weight-loss-specific prescribing picture covers the licensed criteria in more detail.

The private prescription route, what it involves and what it costs

If your GP can't prescribe on the NHS right now, a private prescription through a GPhC-registered online pharmacy is the legal alternative. The process mirrors what a good GP would do: a clinical consultation, identity and weight verification, a prescriber's review of your full history, and then dispensing if you're suitable. The difference is that private services aren't bound by the NHS phase-in criteria, so someone with a BMI of 32 and hypertension (clinically eligible under the SmPC) can be assessed today rather than waiting for an NHS cohort to open.

Cost is a real consideration. Mounjaro's UK private price has risen since Eli Lilly adjusted its list price in September 2025; typical private prices since then range roughly £149 to £375 per month depending on dose and provider. You can explore how Mounjaro is priced privately in the UK for more context on what those figures include and exclude. One honest note: a genuinely low price should raise questions about whether a proper clinical review is actually happening, for a prescription medicine, the clinical process is the point, not an inconvenient step around it.

You can verify any online pharmacy on the GPhC register before handing over any personal or payment details. That check takes about thirty seconds and is the single most useful thing you can do to protect yourself. Stock availability is another practical variable worth checking, see the current Mounjaro stock picture in the UK if supply has been a worry.

What a same-day private consultation looks like at nume

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not automated screening software. Submit your answers by midday Monday to Friday and, if your prescriber confirms you're suitable, your treatment is dispatched the same day. DPD delivers the next working day in plain, unbranded packaging. That 12pm cut-off is worth noting if you're fitting this around the school run or a working day.

There are no subscription traps or auto-renewals. Before every repeat order, a prescriber reviews your progress afresh. If you want to see how the consultation works before committing to anything, our treatment overview covers the full picture, or you can look at Mounjaro specifically including how the dose titration schedule works in practice. Our clinical team oversees all prescribing decisions.

If you have questions before starting, our team is reachable seven days a week, get in touch or check the FAQs for quick answers.